Department of General Medicine, Juntendo University, Tokyo, Japan.
Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.
Crit Care. 2019 Nov 19;23(1):360. doi: 10.1186/s13054-019-2644-x.
Time to antibiotic administration is a key element in sepsis care; however, it is difficult to implement sepsis care bundles. Additionally, sepsis is different from other emergent conditions including acute coronary syndrome, stroke, or trauma. We aimed to describe the association between time to antibiotic administration and outcomes in patients with severe sepsis and septic shock in Japan.
This prospective observational study enrolled 1184 adult patients diagnosed with severe sepsis based on the Sepsis-2 criteria and admitted to 59 intensive care units (ICUs) in Japan between January 1, 2016, and March 31, 2017, as the sepsis cohort of the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) study. We compared the characteristics and in-hospital mortality of patients administered with antibiotics at varying durations after sepsis recognition, i.e., 0-60, 61-120, 121-180, 181-240, 241-360, and 361-1440 min, and estimated the impact of antibiotic timing on risk-adjusted in-hospital mortality using the generalized estimating equation model (GEE) with an exchangeable, within-group correlation matrix, with "hospital" as the grouping variable.
Data from 1124 patients in 54 hospitals were used for analyses. Of these, 30.5% and 73.9% received antibiotics within 1 h and 3 h, respectively. Overall, the median time to antibiotic administration was 102 min [interquartile range (IQR), 55-189]. Compared with patients diagnosed in the emergency department [90 min (IQR, 48-164 min)], time to antibiotic administration was shortest in patients diagnosed in ICUs [60 min (39-180 min)] and longest in patients transferred from wards [120 min (62-226)]. Overall crude mortality was 23.4%, where patients in the 0-60 min group had the highest mortality (28.0%) and a risk-adjusted mortality rate [28.7% (95% CI 23.3-34.1%)], whereas those in the 61-120 min group had the lowest mortality (20.2%) and risk-adjusted mortality rates [21.6% (95% CI 16.5-26.6%)]. Differences in mortality were noted only between the 0-60 min and 61-120 min groups.
We could not find any association between earlier antibiotic administration and reduction in in-hospital mortality in patients with severe sepsis.
给予抗生素的时间是脓毒症治疗的关键因素;然而,脓毒症护理包的实施具有一定难度。此外,脓毒症与其他急症情况(如急性冠状动脉综合征、中风或创伤)不同。我们旨在描述日本重症脓毒症和脓毒性休克患者给予抗生素的时间与结局之间的关联。
本前瞻性观察性研究纳入了 2016 年 1 月 1 日至 2017 年 3 月 31 日期间日本 59 个重症监护病房(ICU)中根据脓毒症-2 标准诊断为重症脓毒症的 1184 例成年患者,作为 Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma(FORECAST)研究中脓毒症队列的一部分。我们比较了在脓毒症确诊后不同时间段(0-60、61-120、121-180、181-240、241-360 和 361-1440 分钟)给予抗生素的患者的特征和院内死亡率,并使用广义估计方程模型(GEE),采用可交换、组内相关矩阵,以“医院”为分组变量,估计抗生素时机对风险调整后院内死亡率的影响。
使用来自 54 家医院的 1124 名患者的数据进行分析。其中,30.5%和 73.9%的患者分别在 1 小时和 3 小时内接受了抗生素治疗。总体而言,抗生素给药的中位时间为 102 分钟[四分位距(IQR),55-189]。与在急诊科确诊的患者[90 分钟(IQR,48-164 分钟)]相比,在 ICU 确诊的患者抗生素给药时间最短[60 分钟(39-180 分钟)],而从病房转来的患者时间最长[120 分钟(62-226 分钟)]。总体粗死亡率为 23.4%,0-60 分钟组的死亡率最高(28.0%),风险调整死亡率为[28.7%(95%CI 23.3-34.1%)],而 61-120 分钟组的死亡率最低(20.2%)和风险调整死亡率[21.6%(95%CI 16.5-26.6%)]。仅在 0-60 分钟组和 61-120 分钟组之间观察到死亡率的差异。
我们未发现给予抗生素时间更早与重症脓毒症患者院内死亡率降低之间存在关联。